CN105001090A - Preparation method of 4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl)-butyl-2-methyl methacrylate - Google Patents

Preparation method of 4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl)-butyl-2-methyl methacrylate Download PDF

Info

Publication number
CN105001090A
CN105001090A CN201510375901.3A CN201510375901A CN105001090A CN 105001090 A CN105001090 A CN 105001090A CN 201510375901 A CN201510375901 A CN 201510375901A CN 105001090 A CN105001090 A CN 105001090A
Authority
CN
China
Prior art keywords
peroxide
benzyl
tin
formula
butyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510375901.3A
Other languages
Chinese (zh)
Inventor
易加明
陶春蕾
陈国祥
邵凤
杨欣怡
王慧
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ANHUI WANBANG MEDICAL TECHNOLOGY Co Ltd
Original Assignee
ANHUI WANBANG MEDICAL TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ANHUI WANBANG MEDICAL TECHNOLOGY Co Ltd filed Critical ANHUI WANBANG MEDICAL TECHNOLOGY Co Ltd
Priority to CN201510375901.3A priority Critical patent/CN105001090A/en
Publication of CN105001090A publication Critical patent/CN105001090A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/317Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention provides a novel preparation method of 4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl)-butyl-2-methyl methacrylate. The intermediate is used for the synthesis of Arctigenin, and has the advantages of economical efficiency, environmental protection, efficiency and high yield.

Description

A kind of 4-acetoxy-3-(3,4-Dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl) preparation method of-but-2-ene acid methyl esters
Technical field
The present invention relates to intermediate 4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl used by synthesis antigout drug l-arctigenin)-but-2-ene acid methyl esters and preparation method thereof.
Background technology
At present, clinical just by (3R, 4R)-4-(3,4-the dimethoxy-benzyl)-3-(4-hydroxyl-3-methoxybenzy described in CN20108001429)-dihydrofuran compound studies as anti-pancreatic cancer cell.Clinical trial needs actual this active medicine of large-scale synthesis, and for the preparation of the intermediate of this active medicine.Therefore, need to find preparation (3R, 4R)-4-(3,4-dimethoxy-benzyl)-3-(4-hydroxyl-3-methoxybenzy) novel synthesis of-dihydrofuran.
Summary of the invention
Accordingly, the present invention relates to l-arctigenin intermediate 4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl)-but-2-ene acid methyl esters.
The present invention relates to and prepare l-arctigenin intermediate 4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl)-but-2-ene acid methyl esters novel method.
In 1-3 case study on implementation, the invention provides a kind of preparation method of formula 2 compound; Comprise:
In a heated condition, in organotin catalyzed and solvent coexisted environment, under initiator causes, formula 1 compound changes formula 2 compound into;
Wherein:
Organotin catalysts is selected from dibutyltin dilaurate, stannous octoate, two (dodecyl sulphur) dibutyl tin, dibutyltin diacetate, dioctyl tin, dialkyl tin dimaleate, two mercaptan tin alkyls, mercaptan dioctyl tin, tributyl tin, perfluoro butyl sulfonic acid tin, fluoridize in tributyltin or three (2-perfluoro hexyl) ethyl stannic hydride one or more;
Solvent is selected from one or more in ethyl acetate, toluene, benzene, methylene dichloride, DMF, DMSO, perfluoromethyl cyclohexane or acetonitrile;
Initiator is selected from organo-peroxide class: benzoyl peroxide, lauroyl peroxide, isopropyl benzene hydroperoxide, tertbutyl peroxide, di-t-butyl peroxide, dicumyl peroxide, peroxidized t-butyl perbenzoate, peroxidation trimethylacetic acid tertiary butyl ester, methylethyl ketone peroxide, cyclohexanone peroxide, di-isopropyl peroxydicarbonate, di-cyclohexylperoxy dicarbonate; Azo: one or more in Diisopropyl azodicarboxylate, 2,2'-Azobis(2,4-dimethylvaleronitrile) or azo-bis-iso-dimethyl;
Temperature of reaction is selected from one or more in 50-60 DEG C.
Embodiment 1:4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl)-but-2-ene acid methyl esters preparation
Take (6.1 g, 10 mmol) 3-acetoxyl group-4-(3, 4-dimethoxy-phenyl)-2-(4-hydroxy-3-methoxy-benzyl)-2-nitro-3-thiophenyl-methyl-butyrate, (0.29 g, 10% mmol) tri-butyl tin hydride, (8.2 mg, 0.5% mmol) Diisopropyl azodicarboxylate adds in 250 mL there-necked flasks, with 50 mL toluene, bottleneck material is washed in bottle, stirring reaction at 50 DEG C, LC follows the tracks of reaction, react 24 h, there is the raw material of 10% unconverted, reaction solution is down to room temperature, 20 mL purified water are added in reaction solution, stir 10 min, leave standstill, separatory, which floor anhydrous sodium sulfate drying is had to be spin-dried for, through column chromatography purification enriched material, obtain yellow oil 1.5 g, yield 35%.
Embodiment 2:4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl)-but-2-ene acid methyl esters preparation
Take (6.1 g, 10 mmol) 3-acetoxyl group-4-(3, 4-dimethoxy-phenyl)-2-(4-hydroxy-3-methoxy-benzyl)-2-nitro-3-thiophenyl-methyl-butyrate, (0.29 g, 10% mmol) tri-butyl tin hydride, add in 250 mL there-necked flasks, with 40 mL toluene, bottleneck material is washed in bottle, with 10 mL toluene by (16.4 mg, 1% mmol) Diisopropyl azodicarboxylate dissolving, in instillation reaction solution, slowly be warming up to 50 DEG C, LC follows the tracks of reaction, react 4 h, raw material is unconverted, reaction solution is down to room temperature, 20 mL purified water are added in reaction solution, stir 10 min, leave standstill, separatory, which floor anhydrous sodium sulfate drying is had to be spin-dried for, through column chromatography purification enriched material, obtain yellow oil 3.9g, yield 90%.
Embodiment 3:4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl)-but-2-ene acid methyl esters preparation
Take (30.2 g, 50 mmol) 3-acetoxyl group-4-(3, 4-dimethoxy-phenyl)-2-(4-hydroxy-3-methoxy-benzyl)-2-nitro-3-thiophenyl-methyl-butyrate, (1.45 g, 10% mmol) tri-butyl tin hydride, add in 1000 mL there-necked flasks, with 200 mL toluene, bottleneck material is washed in bottle, with 50 mL toluene by (41.2mg, 0.5% mmol) Diisopropyl azodicarboxylate dissolving, in instillation reaction solution, slowly be warming up to 50 DEG C, LC follows the tracks of reaction, react 3 h, raw material is unconverted, reaction solution is down to room temperature, 100 mL purified water are added in reaction solution, stir 10 min, leave standstill, separatory, which floor anhydrous sodium sulfate drying is had to be spin-dried for, through column chromatography purification enriched material, obtain yellow oil 19.5 g, yield 88%.

Claims (4)

1. a l-arctigenin intermediate, is characterized in that: described l-arctigenin intermediate is the compound that general formula I represents,
In formula I:
R represents H, COR 1or R 1, wherein R 1represent C 1-18alkane;
R 2represent halogen, SR 1or OR 1, wherein R 1represent C 1-18alkane;
R 3representative, H, COR 1or R 1, wherein R 1represent C 1-18alkane.
2. l-arctigenin intermediate according to claim 1, is characterized in that: in formula I, R is H, R 2for OR 1, R 3for COR 1, R 1for CH 3,, structural formula as shown in Equation 3:
3. the preparation method of formula 2 compound; Comprise:
In a heated condition, in organotin catalyzed and solvent coexisted environment, under initiator causes, formula 1 compound changes formula 2 compound into;
4. method according to claim 3, wherein:
Organotin catalysts is selected from dibutyltin dilaurate, stannous octoate, two (dodecyl sulphur) dibutyl tin, dibutyltin diacetate, dioctyl tin, dialkyl tin dimaleate, two mercaptan tin alkyls, mercaptan dioctyl tin, tributyl tin, perfluoro butyl sulfonic acid tin, fluoridize in tributyltin or three (2-perfluoro hexyl) ethyl stannic hydride one or more;
Solvent is selected from one or more in ethyl acetate, toluene, benzene, methylene dichloride, DMF, DMSO, perfluoromethyl cyclohexane or acetonitrile;
Initiator is selected from organo-peroxide class: benzoyl peroxide, lauroyl peroxide, isopropyl benzene hydroperoxide, tertbutyl peroxide, di-t-butyl peroxide, dicumyl peroxide, peroxidized t-butyl perbenzoate, peroxidation trimethylacetic acid tertiary butyl ester, methylethyl ketone peroxide, cyclohexanone peroxide, di-isopropyl peroxydicarbonate, di-cyclohexylperoxy dicarbonate; Azo: one or more in Diisopropyl azodicarboxylate, 2,2'-Azobis(2,4-dimethylvaleronitrile) or azo-bis-iso-dimethyl;
Temperature of reaction is selected from one or more in 50-60 DEG C.
CN201510375901.3A 2015-07-01 2015-07-01 Preparation method of 4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl)-butyl-2-methyl methacrylate Pending CN105001090A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510375901.3A CN105001090A (en) 2015-07-01 2015-07-01 Preparation method of 4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl)-butyl-2-methyl methacrylate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510375901.3A CN105001090A (en) 2015-07-01 2015-07-01 Preparation method of 4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl)-butyl-2-methyl methacrylate

Publications (1)

Publication Number Publication Date
CN105001090A true CN105001090A (en) 2015-10-28

Family

ID=54374005

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510375901.3A Pending CN105001090A (en) 2015-07-01 2015-07-01 Preparation method of 4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl)-butyl-2-methyl methacrylate

Country Status (1)

Country Link
CN (1) CN105001090A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101104610A (en) * 2006-07-14 2008-01-16 浙江大学 4-deoxyisopodophyllotoxin derivatives, preparation and medicinal uses thereof
CN101736050A (en) * 2009-12-08 2010-06-16 辽宁中医药大学 Preparation method of arctigenin
CN103145655A (en) * 2013-01-09 2013-06-12 南京海昌中药集团有限公司 Preparation method of high-purity arctigenin
CN104447234A (en) * 2014-12-08 2015-03-25 安徽万邦医药科技有限公司 Preparation method of (3R,4R)-4-(3,4-dimethoxybenzyl)-3-(4-hydroxyl-3-methoxybenzyl)-dihydrofuran

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101104610A (en) * 2006-07-14 2008-01-16 浙江大学 4-deoxyisopodophyllotoxin derivatives, preparation and medicinal uses thereof
CN101736050A (en) * 2009-12-08 2010-06-16 辽宁中医药大学 Preparation method of arctigenin
CN103145655A (en) * 2013-01-09 2013-06-12 南京海昌中药集团有限公司 Preparation method of high-purity arctigenin
CN104447234A (en) * 2014-12-08 2015-03-25 安徽万邦医药科技有限公司 Preparation method of (3R,4R)-4-(3,4-dimethoxybenzyl)-3-(4-hydroxyl-3-methoxybenzyl)-dihydrofuran

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NOBORU ONO ET AL.: "A New Synthesis of Allylic Alcohols or Their Derivatives Via Reductive Elimination from γ-phenylthio-8-nitroalcohols with Tributyltinhydride", 《TETRAHEDRON LETTERS》 *

Similar Documents

Publication Publication Date Title
CN103814023B (en) The manufacture method of fluoro-3, the 4-dihydroisoquinoline derivatives of 4,4-bis-
CN107365297B (en) Preparation method and intermediate of 2-methyl-2' -phenylpropionic acid derivative
CN102675285A (en) Method for pure water phase preparation of rabeprazole sodium
CN105001090A (en) Preparation method of 4-acetoxy-3-(3,4-dimethoxy-benzyl)-2-(4-hydroxy-3-methoxy-benzyl)-butyl-2-methyl methacrylate
CN102311457A (en) Preparation method of rosuvastatin
CN102249962B (en) Preparation method of 1,1-disulfur-1-olefin
CA2882138C (en) Process for the synthesis of substituted gamma lactams
CN105272921A (en) Method for preparing Ceritinib and intermediate compound of Ceritinib
CN107089912B (en) Method for selectively catalyzing and synthesizing mandelate compound by metallocene complex
CN103755636A (en) Method for synthesizing Lorcaserin raceme derivative
AU2016102188A4 (en) Pyrazolone drug intermediates acetyl acetanilide synthesis method
CN104910095A (en) Preparation method of 4-substituted-2-aminothiazole compound
CN102633683B (en) Synthesis method of 1-hydroxymethyl cyclopropylacetonitrile
CN102838520A (en) Amisulpride preparation method
CN105348278B (en) A kind of preparation method of butanedioic acid Solifenacin impurity
CN105523939B (en) A kind of preparation method of lenalidomide intermediate
EP3498690A1 (en) Method for preparing intermediate of 6-arylaminopyridonecarboxamide compound as mek inhibitor
CN106866493B (en) A kind of preparation method of Apremilast
AU2016102242A4 (en) Busulfan drug intermediates 1, 4 - methyl sulfonic acid butyl ester synthesis method
CN103664716B (en) 1-(1-virtue sulfuryl) benzyl more creates blue hydrocarbon azulenoid and preparation method thereof
CN103086818A (en) Method for synthesizing alpha-oxyamide with 2-hydroxy propylene cyanide
WO2016043501A1 (en) Method for preparing anhydrosugar alcohol using two-step hydrothermal reaction
CN102126997B (en) Styrene monomer comprising polymerizable double bond and chain transfer sulfydryl and preparation method thereof
CN104447211A (en) Intermediate compound of vitamin D drug, as well as preparation method
JP2012097041A (en) Tetrahydropyrazolopyrazolone derivative having fluoroalkyl group and method of producing the same

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20151028